Merck seeks expanded Welireg label with promising combo data from Keytruda and Lenvima
Merck is pursuing regulatory approval for two new combination therapies involving its drug Welireg for…
Newswire
Henrietta Lacks’ estate settles with Novartis over the ‘stolen cells’ that advanced science
Novartis has settled a lawsuit brought by the estate of Henrietta Lacks, which claimed that…
Eli Lilly and Novo Nordisk Release Key GLP-1 Data Amid Leadership Changes
This week, Eli Lilly and Novo Nordisk unveiled significant data regarding their GLP-1 receptor agonists,…
Kennedy Appoints New Members to Vaccine Advisory Committee Ahead of Rescheduled Meeting
WASHINGTON — Health Secretary Robert F. Kennedy Jr. announced the appointment of two new members…
Ascendis Wins FDA Approval for Achondroplasia Drug, Waits on EU Action
The FDA on Friday granted approval to Ascendis Pharma for its once-weekly treatment, navepegritide, aimed…
Most-Favored Nation Drug Pricing Agreements Set to Expire After Three Years for Some Firms
WASHINGTON — Recent disclosures from Securities and Exchange Commission filings reveal that the “most-favored nation”…
Merck Cuts More Than 150 Jobs at New Gardasil Vaccine Plant in North Carolina
Merck is cutting over 150 jobs at its recently opened Gardasil vaccine manufacturing facility in…
CHMP Recommends Moderna’s Flu-Covid Shot and Novartis Pill for Hives
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the…
Atrium spins out of Avidity, aiming to target rare heart diseases with RNA
Four months after Avidity’s $12 billion buyout, Atrium debuted with $270 million in cash and…
Medicines: Reclassify Your Product
Pharmaceutical companies are now encouraged to apply for the reclassification of their products, transitioning them…